Research Day
HAGAS HEART DISEASE IN THE UNITED STATES - A THIRTEEN YEAR ANALYSIS
Document Type
Abstract
Date
2021
Abstract
Abstract: Introduction: Chagas Heart Disease (CHD) is endemic in Latin America, causes tachyarrhythmias, bradyarrhythmias and heart failure. It is under-recognized in the US. The real epidemiology of CHD is not well known in the USA.
Methods: This study is a retrospective review from the NIS-HCUP Database from 2002-2014. Inclusion criteria consisted of the presence of a billing code for CHD. Two control groups were created; discharged patients with ischemic heart disease (IHD) and with non-ischemic heartdisease (NIHD). We compiled lists of codes for known complications of cardiomyopathies, performed procedures and compared in these groups.
Results: There were 1383 weighted discharges with a billing code for CHD. Length of stay and hospitalization cost medians were higher in CHD group. The majority of the patients with CHD were Hispanic. Patients with CHD, IHD and NIHD were reported with Pulmonary Hypertension in 11.3% 3.09% and 12.46%; with sinoatrial node dysfunction in 4.5%,1.52% and 2.11%; with atrial tachyarrhythmias in 32.06%, 21.39% and 35.07%; with heart failure in 65.6%, 28.16% and 53.69%; with severe AV node block in 5.57%, 0.9% 1.36%; with stroke in 6.85%, 0.9% and 1.36%; with ventricular arrythmias in 23.88%, 7.22% and 6.57%. The proportion of CHD, IHD and NIHD that resulted in death during hospitalization was 3.21%, 3.40% and 4.29%.
Conclusions: Our study identified a low occurrence of CHD in the USA over 13-year study period. While the prevalence for CHD is low, it is important that clinicians be aware of this diagnosis due the mortality and morbidity associated.